The pharmacology of extrapyramidal movement disorders.
D001480:Basal Ganglia Diseases / Q000188:drug therapy*; D002819:Chorea / Q000209:etiology; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000502:physiology; D004422:Dystonia Musculorum Deformans / Q000188:drug therapy; D006527:Hepatolenticular Degeneration / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis / Q000503:physiopathology; D006980:Hyperthyroidism / Q000503:physiopathology; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D020149:Manganese Poisoning; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy*; D010275:Parasympathetic Nervous System / Q000503:physiopathology; D010300:Parkinson Disease / Q000188:drug therapy / Q000503:physiopathology
D004295:Dihydroxyphenylalanine; D004298:Dopamine